Gene Symbol | Gene ID | Gene Info |
---|---|---|
ESRRA
|
ENSG00000173153.9 | estrogen related receptor alpha |
ESR2
|
ENSG00000140009.14 | estrogen receptor 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_64720582_64720733 | ESR2 | 29046 | 0.171076 | -0.62 | 7.5e-02 | Click! |
chr14_64759811_64759962 | ESR2 | 1192 | 0.516523 | -0.52 | 1.5e-01 | Click! |
chr14_64720750_64720901 | ESR2 | 28878 | 0.171524 | -0.43 | 2.5e-01 | Click! |
chr14_64804508_64805275 | ESR2 | 61 | 0.865505 | 0.14 | 7.2e-01 | Click! |
chr14_64804121_64804291 | ESR2 | 608 | 0.556640 | -0.14 | 7.2e-01 | Click! |
chr11_64071742_64071893 | ESRRA | 1227 | 0.196322 | 0.64 | 6.1e-02 | Click! |
chr11_64071910_64072476 | ESRRA | 851 | 0.304076 | 0.62 | 7.4e-02 | Click! |
chr11_64081738_64081889 | ESRRA | 57 | 0.916906 | -0.59 | 9.8e-02 | Click! |
chr11_64073389_64074392 | ESRRA | 28 | 0.924495 | 0.55 | 1.3e-01 | Click! |
chr11_64074500_64074651 | ESRRA | 657 | 0.408482 | 0.51 | 1.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_95727852_95728104 | 3.04 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
1735 |
0.41 |
chr1_161038546_161039545 | 2.93 |
ARHGAP30 |
Rho GTPase activating protein 30 |
411 |
0.65 |
chr13_113622985_113623455 | 2.79 |
MCF2L-AS1 |
MCF2L antisense RNA 1 |
82 |
0.79 |
chr1_26872331_26872899 | 2.68 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
272 |
0.88 |
chr14_93118654_93119048 | 2.63 |
RIN3 |
Ras and Rab interactor 3 |
5 |
0.99 |
chr17_7239932_7240900 | 2.52 |
ACAP1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
507 |
0.51 |
chr17_56410108_56410593 | 2.40 |
MIR142 |
microRNA 142 |
481 |
0.66 |
chr17_265803_266293 | 2.26 |
AC108004.3 |
|
2234 |
0.23 |
chr9_95822109_95822464 | 2.21 |
SUSD3 |
sushi domain containing 3 |
1225 |
0.45 |
chr12_51717169_51717830 | 2.20 |
BIN2 |
bridging integrator 2 |
400 |
0.82 |
chr7_38389675_38390189 | 2.19 |
AMPH |
amphiphysin |
112781 |
0.07 |
chr11_118094529_118095128 | 2.17 |
AMICA1 |
adhesion molecule, interacts with CXADR antigen 1 |
26 |
0.97 |
chr12_58135257_58135844 | 2.12 |
AGAP2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
390 |
0.63 |
chr11_104904746_104905919 | 2.11 |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
508 |
0.77 |
chr17_73840046_73840332 | 2.10 |
UNC13D |
unc-13 homolog D (C. elegans) |
226 |
0.84 |
chr19_6481304_6482171 | 2.09 |
DENND1C |
DENN/MADD domain containing 1C |
27 |
0.95 |
chr16_30484007_30484505 | 2.07 |
ITGAL |
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
184 |
0.81 |
chr19_3136242_3137376 | 2.02 |
GNA15 |
guanine nucleotide binding protein (G protein), alpha 15 (Gq class) |
618 |
0.58 |
chr8_134079225_134079805 | 2.02 |
SLA |
Src-like-adaptor |
6912 |
0.26 |
chr11_65408534_65408946 | 1.97 |
SIPA1 |
signal-induced proliferation-associated 1 |
441 |
0.63 |
chr2_85804717_85805457 | 1.93 |
VAMP8 |
vesicle-associated membrane protein 8 |
371 |
0.72 |
chr19_1068246_1068401 | 1.92 |
HMHA1 |
histocompatibility (minor) HA-1 |
826 |
0.4 |
chr9_134127628_134128133 | 1.90 |
FAM78A |
family with sequence similarity 78, member A |
18000 |
0.15 |
chr11_65184608_65185159 | 1.88 |
ENSG00000245532 |
. |
27046 |
0.09 |
chr19_1258842_1259341 | 1.88 |
CIRBP |
cold inducible RNA binding protein |
293 |
0.78 |
chr11_121324494_121324645 | 1.88 |
RP11-730K11.1 |
|
847 |
0.59 |
chr19_54881402_54882266 | 1.87 |
LAIR1 |
leukocyte-associated immunoglobulin-like receptor 1 |
224 |
0.88 |
chr19_952910_953260 | 1.86 |
ARID3A |
AT rich interactive domain 3A (BRIGHT-like) |
20576 |
0.07 |
chr5_176785343_176785607 | 1.85 |
RGS14 |
regulator of G-protein signaling 14 |
637 |
0.54 |
chr19_7413904_7414409 | 1.83 |
CTB-133G6.1 |
|
308 |
0.88 |
chr19_14551433_14551660 | 1.83 |
PKN1 |
protein kinase N1 |
474 |
0.7 |
chr19_4916483_4916936 | 1.81 |
ARRDC5 |
arrestin domain containing 5 |
13830 |
0.12 |
chr20_62369505_62369786 | 1.80 |
RP4-583P15.14 |
|
22 |
0.92 |
chr1_9690042_9690512 | 1.77 |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
21513 |
0.15 |
chr12_122225090_122225354 | 1.76 |
RHOF |
ras homolog family member F (in filopodia) |
6044 |
0.17 |
chr7_38398847_38399253 | 1.76 |
AMPH |
amphiphysin |
103663 |
0.08 |
chr14_100531999_100532513 | 1.75 |
EVL |
Enah/Vasp-like |
498 |
0.76 |
chr11_280700_281222 | 1.74 |
NLRP6 |
NLR family, pyrin domain containing 6 |
2391 |
0.12 |
chr20_62271176_62271486 | 1.74 |
CTD-3184A7.4 |
|
12728 |
0.09 |
chr20_56193926_56194226 | 1.74 |
ZBP1 |
Z-DNA binding protein 1 |
1374 |
0.49 |
chr1_111745814_111746254 | 1.73 |
DENND2D |
DENN/MADD domain containing 2D |
997 |
0.41 |
chr21_46340531_46340791 | 1.71 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
109 |
0.73 |
chr19_39108076_39108634 | 1.69 |
MAP4K1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
209 |
0.87 |
chr5_169724277_169724686 | 1.69 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
750 |
0.71 |
chr19_16254556_16255035 | 1.68 |
HSH2D |
hematopoietic SH2 domain containing |
249 |
0.88 |
chr1_154981512_154981710 | 1.68 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
5313 |
0.08 |
chr15_77287809_77288285 | 1.67 |
PSTPIP1 |
proline-serine-threonine phosphatase interacting protein 1 |
132 |
0.96 |
chr7_150264558_150265605 | 1.67 |
GIMAP4 |
GTPase, IMAP family member 4 |
557 |
0.78 |
chr11_82828119_82828301 | 1.66 |
PCF11 |
PCF11 cleavage and polyadenylation factor subunit |
39820 |
0.12 |
chr20_4795670_4795862 | 1.65 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
3 |
0.98 |
chr2_240187102_240187645 | 1.64 |
ENSG00000265215 |
. |
39784 |
0.13 |
chr19_10449910_10450285 | 1.62 |
ICAM3 |
intercellular adhesion molecule 3 |
198 |
0.86 |
chr22_40858929_40859404 | 1.57 |
MKL1 |
megakaryoblastic leukemia (translocation) 1 |
256 |
0.92 |
chr17_56408975_56409725 | 1.56 |
MIR142 |
microRNA 142 |
519 |
0.63 |
chr7_157405294_157405606 | 1.55 |
AC005481.5 |
Uncharacterized protein |
1265 |
0.52 |
chr9_134150778_134151758 | 1.55 |
FAM78A |
family with sequence similarity 78, member A |
666 |
0.69 |
chr11_46367119_46367443 | 1.54 |
DGKZ |
diacylglycerol kinase, zeta |
294 |
0.88 |
chr14_76009252_76009829 | 1.53 |
BATF |
basic leucine zipper transcription factor, ATF-like |
20637 |
0.15 |
chr15_75081452_75081829 | 1.53 |
ENSG00000264386 |
. |
542 |
0.49 |
chr6_167369037_167370142 | 1.52 |
RP11-514O12.4 |
|
23 |
0.9 |
chr7_73624740_73625015 | 1.52 |
LAT2 |
linker for activation of T cells family, member 2 |
524 |
0.74 |
chr19_42705324_42705475 | 1.51 |
ENSG00000265122 |
. |
8169 |
0.09 |
chr11_65185943_65186437 | 1.51 |
ENSG00000245532 |
. |
25739 |
0.09 |
chr17_76123369_76123520 | 1.51 |
TMC6 |
transmembrane channel-like 6 |
343 |
0.8 |
chr12_25207113_25207806 | 1.50 |
LRMP |
lymphoid-restricted membrane protein |
1785 |
0.37 |
chr11_47416652_47416817 | 1.50 |
RP11-750H9.5 |
|
457 |
0.65 |
chr11_104914891_104915295 | 1.50 |
CARD16 |
caspase recruitment domain family, member 16 |
941 |
0.54 |
chr11_47380887_47381038 | 1.49 |
MYBPC3 |
myosin binding protein C, cardiac |
6709 |
0.11 |
chr11_46367528_46367907 | 1.49 |
DGKZ |
diacylglycerol kinase, zeta |
730 |
0.6 |
chr11_1874347_1875032 | 1.47 |
LSP1 |
lymphocyte-specific protein 1 |
489 |
0.65 |
chr19_49838375_49839003 | 1.47 |
CD37 |
CD37 molecule |
5 |
0.95 |
chr17_43301591_43301923 | 1.47 |
CTD-2020K17.1 |
|
2168 |
0.16 |
chr1_32718292_32718517 | 1.46 |
LCK |
lymphocyte-specific protein tyrosine kinase |
1529 |
0.2 |
chr22_37680309_37680627 | 1.46 |
CYTH4 |
cytohesin 4 |
1940 |
0.3 |
chr2_231090336_231091061 | 1.46 |
SP140 |
SP140 nuclear body protein |
219 |
0.54 |
chr12_117536177_117536841 | 1.45 |
TESC |
tescalcin |
742 |
0.76 |
chr19_3179462_3180177 | 1.44 |
S1PR4 |
sphingosine-1-phosphate receptor 4 |
1083 |
0.38 |
chr7_45016674_45016991 | 1.44 |
MYO1G |
myosin IG |
1865 |
0.25 |
chr7_150148744_150149359 | 1.43 |
GIMAP8 |
GTPase, IMAP family member 8 |
1333 |
0.41 |
chrX_48542477_48542733 | 1.43 |
WAS |
Wiskott-Aldrich syndrome |
437 |
0.75 |
chr15_81586633_81587120 | 1.42 |
IL16 |
interleukin 16 |
2378 |
0.31 |
chr9_139427949_139428157 | 1.42 |
RP11-413M3.4 |
|
9280 |
0.09 |
chr19_2290395_2291381 | 1.39 |
LINGO3 |
leucine rich repeat and Ig domain containing 3 |
1135 |
0.28 |
chr16_50714281_50714981 | 1.39 |
SNX20 |
sorting nexin 20 |
592 |
0.64 |
chr22_44577668_44577918 | 1.38 |
PARVG |
parvin, gamma |
52 |
0.99 |
chr20_47437784_47438180 | 1.38 |
PREX1 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
6438 |
0.29 |
chr1_12230241_12230523 | 1.38 |
TNFRSF1B |
tumor necrosis factor receptor superfamily, member 1B |
3322 |
0.2 |
chr12_4381475_4382675 | 1.38 |
CCND2 |
cyclin D2 |
863 |
0.52 |
chr7_128579388_128579603 | 1.38 |
IRF5 |
interferon regulatory factor 5 |
765 |
0.6 |
chr11_67172347_67172531 | 1.38 |
TBC1D10C |
TBC1 domain family, member 10C |
779 |
0.35 |
chr6_30798000_30798388 | 1.37 |
ENSG00000202241 |
. |
33833 |
0.07 |
chrX_48772131_48772362 | 1.36 |
PIM2 |
pim-2 oncogene |
766 |
0.45 |
chr15_52023462_52024365 | 1.36 |
LYSMD2 |
LysM, putative peptidoglycan-binding, domain containing 2 |
6405 |
0.15 |
chr10_135088849_135089035 | 1.36 |
ADAM8 |
ADAM metallopeptidase domain 8 |
1412 |
0.25 |
chr18_77283391_77284187 | 1.36 |
AC018445.1 |
Uncharacterized protein |
7732 |
0.29 |
chr5_150602561_150602806 | 1.36 |
CCDC69 |
coiled-coil domain containing 69 |
1023 |
0.53 |
chr16_30106167_30106460 | 1.36 |
YPEL3 |
yippee-like 3 (Drosophila) |
1020 |
0.25 |
chr22_37545294_37545803 | 1.35 |
IL2RB |
interleukin 2 receptor, beta |
482 |
0.7 |
chr16_28996496_28996848 | 1.34 |
LAT |
linker for activation of T cells |
11 |
0.94 |
chr10_134260489_134261029 | 1.34 |
C10orf91 |
chromosome 10 open reading frame 91 |
2066 |
0.3 |
chr14_99734743_99735157 | 1.34 |
BCL11B |
B-cell CLL/lymphoma 11B (zinc finger protein) |
2615 |
0.3 |
chr1_202129278_202129681 | 1.34 |
PTPN7 |
protein tyrosine phosphatase, non-receptor type 7 |
251 |
0.89 |
chr13_114831006_114831265 | 1.34 |
RASA3 |
RAS p21 protein activator 3 |
12303 |
0.24 |
chr2_204801338_204802214 | 1.33 |
ICOS |
inducible T-cell co-stimulator |
273 |
0.95 |
chr9_134149437_134149588 | 1.33 |
FAM78A |
family with sequence similarity 78, member A |
2422 |
0.27 |
chr16_50308522_50308701 | 1.32 |
ADCY7 |
adenylate cyclase 7 |
547 |
0.79 |
chr9_139923413_139923722 | 1.32 |
ABCA2 |
ATP-binding cassette, sub-family A (ABC1), member 2 |
827 |
0.27 |
chr17_43487096_43487739 | 1.32 |
ARHGAP27 |
Rho GTPase activating protein 27 |
335 |
0.82 |
chr10_26727488_26728306 | 1.31 |
APBB1IP |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
543 |
0.85 |
chr22_44391651_44392034 | 1.30 |
PARVB |
parvin, beta |
3249 |
0.27 |
chr1_209930701_209930998 | 1.30 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
994 |
0.46 |
chr19_36398415_36398818 | 1.30 |
TYROBP |
TYRO protein tyrosine kinase binding protein |
533 |
0.58 |
chr21_43483378_43483554 | 1.29 |
UMODL1 |
uromodulin-like 1 |
398 |
0.86 |
chr12_7061050_7061251 | 1.29 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
612 |
0.41 |
chr8_142255255_142255924 | 1.29 |
RP11-10J21.4 |
|
7802 |
0.15 |
chr17_72733506_72734386 | 1.29 |
RAB37 |
RAB37, member RAS oncogene family |
575 |
0.59 |
chr21_35304396_35305066 | 1.28 |
LINC00649 |
long intergenic non-protein coding RNA 649 |
1213 |
0.41 |
chr12_53600321_53600967 | 1.28 |
ITGB7 |
integrin, beta 7 |
356 |
0.78 |
chr17_61779840_61780056 | 1.28 |
LIMD2 |
LIM domain containing 2 |
1416 |
0.31 |
chr6_35270264_35270539 | 1.27 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
4772 |
0.2 |
chr1_151028880_151029472 | 1.27 |
MLLT11 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11 |
1058 |
0.29 |
chr12_4385782_4386106 | 1.27 |
CCND2-AS1 |
CCND2 antisense RNA 1 |
594 |
0.46 |
chr9_95727201_95727619 | 1.27 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
1167 |
0.54 |
chr1_39680841_39681106 | 1.27 |
RP11-416A14.1 |
|
8789 |
0.18 |
chr21_46339892_46340194 | 1.26 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
727 |
0.4 |
chr3_176919226_176919959 | 1.26 |
TBL1XR1 |
transducin (beta)-like 1 X-linked receptor 1 |
4331 |
0.31 |
chr20_62709494_62709725 | 1.26 |
RGS19 |
regulator of G-protein signaling 19 |
1236 |
0.25 |
chrX_128920138_128920289 | 1.26 |
SASH3 |
SAM and SH3 domain containing 3 |
6253 |
0.21 |
chr4_2802491_2802761 | 1.26 |
SH3BP2 |
SH3-domain binding protein 2 |
1901 |
0.35 |
chr1_203242727_203243151 | 1.26 |
BTG2 |
BTG family, member 2 |
31725 |
0.13 |
chr14_105527312_105527781 | 1.25 |
GPR132 |
G protein-coupled receptor 132 |
3727 |
0.23 |
chr8_142105442_142105593 | 1.25 |
DENND3 |
DENN/MADD domain containing 3 |
21860 |
0.19 |
chr5_175085682_175085863 | 1.25 |
HRH2 |
histamine receptor H2 |
739 |
0.7 |
chr11_64642207_64642476 | 1.25 |
EHD1 |
EH-domain containing 1 |
797 |
0.45 |
chr9_130666481_130666789 | 1.25 |
ST6GALNAC6 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 |
974 |
0.33 |
chr17_56413846_56414087 | 1.24 |
ENSG00000264399 |
. |
583 |
0.4 |
chr14_23588365_23588516 | 1.23 |
CEBPE |
CCAAT/enhancer binding protein (C/EBP), epsilon |
385 |
0.75 |
chr22_37637944_37638095 | 1.23 |
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
2269 |
0.23 |
chr2_202098499_202098878 | 1.23 |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
459 |
0.82 |
chr17_76255043_76255413 | 1.23 |
TMEM235 |
transmembrane protein 235 |
27106 |
0.12 |
chr5_176786759_176786924 | 1.23 |
RGS14 |
regulator of G-protein signaling 14 |
2003 |
0.18 |
chr3_5019013_5019527 | 1.23 |
BHLHE40 |
basic helix-loop-helix family, member e40 |
1531 |
0.38 |
chr17_38483011_38483310 | 1.23 |
RARA |
retinoic acid receptor, alpha |
8623 |
0.11 |
chr1_202130035_202130186 | 1.22 |
PTPN7 |
protein tyrosine phosphatase, non-receptor type 7 |
338 |
0.84 |
chr15_81590554_81590826 | 1.22 |
IL16 |
interleukin 16 |
1067 |
0.54 |
chr3_183273082_183273407 | 1.21 |
KLHL6 |
kelch-like family member 6 |
233 |
0.92 |
chr1_198611164_198611406 | 1.21 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
2993 |
0.32 |
chr14_22988565_22988896 | 1.21 |
TRAJ15 |
T cell receptor alpha joining 15 |
9850 |
0.11 |
chr11_67173386_67173537 | 1.21 |
TBC1D10C |
TBC1 domain family, member 10C |
1801 |
0.14 |
chr16_745762_746190 | 1.20 |
FBXL16 |
F-box and leucine-rich repeat protein 16 |
49 |
0.9 |
chr20_62369822_62370052 | 1.20 |
RP4-583P15.14 |
|
314 |
0.7 |
chr18_60193065_60194045 | 1.20 |
ZCCHC2 |
zinc finger, CCHC domain containing 2 |
2703 |
0.37 |
chr7_45017874_45018185 | 1.19 |
MYO1G |
myosin IG |
668 |
0.61 |
chrX_78620994_78621299 | 1.19 |
ITM2A |
integral membrane protein 2A |
1710 |
0.55 |
chr1_198612556_198613143 | 1.19 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
4557 |
0.28 |
chr17_43300498_43300952 | 1.19 |
CTD-2020K17.1 |
|
1136 |
0.27 |
chr19_13206703_13207270 | 1.19 |
LYL1 |
lymphoblastic leukemia derived sequence 1 |
6695 |
0.11 |
chr4_90228457_90229530 | 1.18 |
GPRIN3 |
GPRIN family member 3 |
168 |
0.97 |
chr16_745521_745735 | 1.18 |
FBXL16 |
F-box and leucine-rich repeat protein 16 |
397 |
0.57 |
chr15_31623610_31623861 | 1.18 |
KLF13 |
Kruppel-like factor 13 |
4677 |
0.34 |
chr7_50349443_50349694 | 1.18 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
1250 |
0.61 |
chr14_74211134_74211285 | 1.18 |
ELMSAN1 |
ELM2 and Myb/SANT-like domain containing 1 |
4251 |
0.14 |
chr11_3876946_3878257 | 1.17 |
STIM1 |
stromal interaction molecule 1 |
189 |
0.59 |
chr12_122230087_122230336 | 1.17 |
RHOF |
ras homolog family member F (in filopodia) |
1055 |
0.48 |
chr17_33640471_33640814 | 1.17 |
SLFN11 |
schlafen family member 11 |
39508 |
0.12 |
chr5_150593652_150593827 | 1.17 |
GM2A |
GM2 ganglioside activator |
2028 |
0.31 |
chr8_134086172_134086360 | 1.17 |
SLA |
Src-like-adaptor |
13663 |
0.23 |
chr16_23847524_23848074 | 1.17 |
PRKCB |
protein kinase C, beta |
396 |
0.89 |
chr6_36098764_36099262 | 1.17 |
MAPK13 |
mitogen-activated protein kinase 13 |
573 |
0.74 |
chr4_8200922_8201607 | 1.16 |
SH3TC1 |
SH3 domain and tetratricopeptide repeats 1 |
166 |
0.96 |
chr19_13212467_13212618 | 1.16 |
LYL1 |
lymphoblastic leukemia derived sequence 1 |
1139 |
0.32 |
chr2_233946751_233946902 | 1.16 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
21637 |
0.18 |
chr12_111866407_111866581 | 1.15 |
SH2B3 |
SH2B adaptor protein 3 |
6172 |
0.2 |
chr3_47023261_47023739 | 1.15 |
CCDC12 |
coiled-coil domain containing 12 |
28 |
0.97 |
chr1_160548800_160549253 | 1.15 |
CD84 |
CD84 molecule |
237 |
0.91 |
chr4_40202563_40202865 | 1.15 |
RHOH |
ras homolog family member H |
750 |
0.7 |
chr4_2813731_2813882 | 1.14 |
SH3BP2 |
SH3-domain binding protein 2 |
140 |
0.96 |
chr9_130539368_130539592 | 1.14 |
SH2D3C |
SH2 domain containing 3C |
1540 |
0.21 |
chr7_137620698_137620944 | 1.14 |
CREB3L2 |
cAMP responsive element binding protein 3-like 2 |
2185 |
0.34 |
chr1_198632521_198632794 | 1.14 |
RP11-553K8.5 |
|
3533 |
0.3 |
chr7_2568940_2569293 | 1.14 |
ENSG00000264357 |
. |
2408 |
0.22 |
chr17_4384641_4384911 | 1.13 |
RP13-580F15.2 |
|
2103 |
0.23 |
chrX_129225814_129226276 | 1.13 |
ELF4 |
E74-like factor 4 (ets domain transcription factor) |
18291 |
0.19 |
chr11_6766362_6766695 | 1.13 |
GVINP1 |
GTPase, very large interferon inducible pseudogene 1 |
23417 |
0.11 |
chr22_37258145_37258296 | 1.13 |
NCF4 |
neutrophil cytosolic factor 4, 40kDa |
1190 |
0.38 |
chr19_39368986_39369494 | 1.13 |
RINL |
Ras and Rab interactor-like |
321 |
0.74 |
chr1_26316819_26316970 | 1.12 |
PAFAH2 |
platelet-activating factor acetylhydrolase 2, 40kDa |
7218 |
0.1 |
chr2_198172097_198172605 | 1.12 |
ANKRD44 |
ankyrin repeat domain 44 |
3160 |
0.2 |
chr1_40849833_40850457 | 1.12 |
SMAP2 |
small ArfGAP2 |
9825 |
0.18 |
chrX_106958420_106958715 | 1.12 |
TSC22D3 |
TSC22 domain family, member 3 |
1064 |
0.59 |
chr21_45773621_45773812 | 1.12 |
TRPM2 |
transient receptor potential cation channel, subfamily M, member 2 |
145 |
0.91 |
chr11_121330361_121330648 | 1.12 |
RP11-730K11.1 |
|
6782 |
0.25 |
chr14_100533458_100533776 | 1.11 |
EVL |
Enah/Vasp-like |
843 |
0.55 |
chr19_42705548_42705699 | 1.11 |
ENSG00000265122 |
. |
8393 |
0.09 |
chr8_134071502_134071774 | 1.11 |
SLA |
Src-like-adaptor |
965 |
0.65 |
chr9_117134390_117135168 | 1.11 |
AKNA |
AT-hook transcription factor |
4465 |
0.23 |
chrX_153190817_153191535 | 1.10 |
ARHGAP4 |
Rho GTPase activating protein 4 |
522 |
0.6 |
chr6_20206247_20206398 | 1.10 |
RP11-239H6.2 |
|
5996 |
0.24 |
chr7_151046647_151046863 | 1.10 |
NUB1 |
negative regulator of ubiquitin-like proteins 1 |
4324 |
0.18 |
chr20_50158730_50159057 | 1.10 |
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
365 |
0.92 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 1.8 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
1.6 | 4.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.4 | 8.3 | GO:0045588 | regulation of gamma-delta T cell differentiation(GO:0045586) positive regulation of gamma-delta T cell differentiation(GO:0045588) |
1.3 | 3.8 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
1.3 | 1.3 | GO:0046645 | regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.2 | 4.6 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.1 | 4.6 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
1.1 | 3.4 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.0 | 3.1 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
1.0 | 3.0 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
1.0 | 3.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.0 | 2.9 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.9 | 4.7 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.9 | 0.9 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.9 | 1.7 | GO:0033622 | integrin activation(GO:0033622) |
0.8 | 1.7 | GO:0045630 | positive regulation of type 2 immune response(GO:0002830) positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.8 | 6.6 | GO:0007172 | signal complex assembly(GO:0007172) |
0.8 | 0.8 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.8 | 4.7 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.8 | 3.9 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.8 | 3.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.8 | 6.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.8 | 3.8 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.7 | 2.2 | GO:0045056 | transcytosis(GO:0045056) |
0.7 | 2.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.7 | 2.6 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.6 | 1.3 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.6 | 1.9 | GO:0015809 | arginine transport(GO:0015809) |
0.6 | 1.3 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.6 | 2.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.6 | 1.9 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.6 | 2.5 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.6 | 0.6 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.6 | 1.8 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.6 | 3.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.6 | 1.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.6 | 2.4 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.6 | 1.2 | GO:0002524 | hypersensitivity(GO:0002524) regulation of acute inflammatory response to antigenic stimulus(GO:0002864) regulation of hypersensitivity(GO:0002883) |
0.6 | 0.6 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.6 | 1.8 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.6 | 0.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.6 | 2.3 | GO:0003093 | regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
0.6 | 2.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.6 | 2.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.6 | 1.7 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.6 | 0.6 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.5 | 0.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.5 | 1.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.5 | 1.1 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.5 | 1.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.5 | 3.2 | GO:0043368 | positive T cell selection(GO:0043368) |
0.5 | 11.7 | GO:0045576 | mast cell activation(GO:0045576) |
0.5 | 2.1 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.5 | 1.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.5 | 2.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.5 | 1.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.5 | 3.0 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.5 | 3.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.5 | 8.5 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.5 | 1.0 | GO:0032898 | neurotrophin production(GO:0032898) |
0.5 | 1.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.5 | 1.5 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.5 | 1.5 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.5 | 3.4 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.5 | 2.4 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.5 | 1.0 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.5 | 0.9 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.5 | 0.5 | GO:0070265 | necrotic cell death(GO:0070265) |
0.5 | 0.9 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.5 | 2.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.5 | 0.9 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.5 | 1.8 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.5 | 1.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.5 | 0.9 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.5 | 0.5 | GO:0051023 | immunoglobulin secretion(GO:0048305) regulation of immunoglobulin secretion(GO:0051023) |
0.4 | 0.4 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.4 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.4 | 2.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.4 | 1.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.4 | 1.3 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.4 | 1.7 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.4 | 1.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.4 | 1.7 | GO:0018101 | protein citrullination(GO:0018101) |
0.4 | 1.3 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.4 | 1.3 | GO:0043276 | anoikis(GO:0043276) |
0.4 | 1.3 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.4 | 4.2 | GO:0090200 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.4 | 1.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 1.2 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.4 | 0.8 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.4 | 0.4 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.4 | 1.2 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.4 | 1.6 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.4 | 0.4 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.4 | 1.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.4 | 1.6 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.4 | 1.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.4 | 1.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.4 | 0.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.4 | 1.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 1.2 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.4 | 0.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.4 | 1.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.4 | 2.7 | GO:0036230 | granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
0.4 | 0.4 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.4 | 3.9 | GO:0045730 | respiratory burst(GO:0045730) |
0.4 | 0.8 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.4 | 0.4 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.4 | 3.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 1.5 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.4 | 1.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.4 | 2.7 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.4 | 1.9 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 1.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.4 | 0.4 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.4 | 3.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.4 | 16.7 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.4 | 1.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 1.8 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.4 | 2.2 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.4 | 0.4 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.4 | 0.4 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.4 | 1.4 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.4 | 5.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.3 | 1.0 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.3 | 0.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 5.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.3 | 16.0 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.3 | 0.7 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.3 | 2.0 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.3 | 0.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 0.3 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.3 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.3 | 0.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.3 | 1.6 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.3 | 3.2 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.3 | 1.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 4.8 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.3 | 0.9 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 0.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.3 | 4.7 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.3 | 0.9 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.3 | 1.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 1.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 0.3 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.3 | 1.8 | GO:0006265 | DNA topological change(GO:0006265) |
0.3 | 0.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 1.5 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.3 | 1.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 0.6 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.3 | 12.0 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.3 | 1.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 3.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.3 | 1.8 | GO:0032613 | interleukin-10 production(GO:0032613) |
0.3 | 5.9 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.3 | 1.2 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.3 | 0.9 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 0.6 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.3 | 4.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.3 | 0.9 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 3.5 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.3 | 1.7 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.3 | 0.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 1.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 5.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 0.6 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.3 | 2.8 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.3 | 0.8 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.3 | 2.5 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.3 | 1.4 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.3 | 1.1 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.3 | 0.8 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.3 | 0.5 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.3 | 0.8 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.3 | 4.6 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 0.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 1.1 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.3 | 0.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 0.8 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.3 | 1.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 1.1 | GO:0042116 | macrophage activation(GO:0042116) |
0.3 | 1.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 0.5 | GO:0001820 | serotonin secretion(GO:0001820) |
0.3 | 0.5 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.3 | 1.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 1.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 0.5 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 1.1 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) negative regulation of growth of symbiont in host(GO:0044130) modulation of growth of symbiont involved in interaction with host(GO:0044144) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.3 | 0.8 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.3 | 2.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.3 | 0.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.3 | 0.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 0.5 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.3 | 0.8 | GO:0015825 | L-serine transport(GO:0015825) |
0.3 | 0.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.3 | 0.5 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.3 | 0.5 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.3 | 0.8 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.3 | 0.3 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.3 | 0.8 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.3 | 0.8 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 1.5 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.3 | 1.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 0.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.3 | 1.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.3 | 0.3 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.2 | 1.0 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.2 | 0.7 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.2 | 1.0 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.2 | 0.7 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.2 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.7 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 2.4 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 0.5 | GO:0010447 | response to acidic pH(GO:0010447) |
0.2 | 0.5 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.2 | 1.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 1.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 1.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.2 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 0.2 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.2 | 1.7 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.5 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 1.2 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.2 | 0.5 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.2 | 0.7 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 0.2 | GO:0032329 | serine transport(GO:0032329) |
0.2 | 0.2 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 4.3 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.2 | 0.7 | GO:0045007 | depurination(GO:0045007) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 1.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.2 | 7.4 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.2 | 0.7 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.2 | 1.2 | GO:0015840 | urea transport(GO:0015840) |
0.2 | 0.7 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.2 | 0.5 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 0.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.9 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.2 | 20.3 | GO:0007159 | leukocyte cell-cell adhesion(GO:0007159) |
0.2 | 0.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 0.9 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 1.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 1.2 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 0.5 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 4.4 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.2 | 0.9 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.2 | 0.9 | GO:0001906 | cell killing(GO:0001906) |
0.2 | 2.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.7 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.5 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.2 | 0.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.2 | 0.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 1.3 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.2 | 0.4 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.2 | 0.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 0.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.7 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 0.2 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 0.7 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.2 | 0.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.2 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.6 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.2 | 1.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 1.1 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.2 | 0.6 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 0.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 1.9 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 1.0 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.2 | 0.2 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.2 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.6 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 0.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.2 | 1.7 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.2 | 1.4 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 1.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 0.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.2 | GO:0021819 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.2 | 1.8 | GO:0016577 | histone demethylation(GO:0016577) |
0.2 | 1.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 0.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.2 | 0.4 | GO:0032202 | telomere assembly(GO:0032202) |
0.2 | 0.4 | GO:0097576 | vacuole fusion(GO:0097576) |
0.2 | 0.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 0.8 | GO:0042026 | protein refolding(GO:0042026) |
0.2 | 1.0 | GO:0034311 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.2 | 1.0 | GO:0051383 | kinetochore organization(GO:0051383) |
0.2 | 0.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 1.4 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.2 | 0.4 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 0.4 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.2 | 0.4 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.2 | 2.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 6.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 0.6 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.2 | 0.8 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.2 | 0.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 0.4 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.2 | 0.4 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.2 | 0.2 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.2 | 0.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 1.0 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.2 | 0.6 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.2 | 0.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 0.2 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.2 | 1.7 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.2 | 1.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 1.0 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 0.6 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.2 | 0.4 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.2 | 0.2 | GO:0033197 | response to vitamin E(GO:0033197) |
0.2 | 0.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.6 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 3.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.2 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 1.1 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.2 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 1.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.9 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.2 | 1.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 0.6 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.6 | GO:0060872 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
0.2 | 1.5 | GO:0019682 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.2 | 1.6 | GO:0006027 | aminoglycan catabolic process(GO:0006026) glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.5 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 1.3 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 0.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) auditory receptor cell fate determination(GO:0042668) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 1.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 2.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 9.0 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.2 | 0.5 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 0.7 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.2 | 0.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.9 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 1.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 1.6 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.7 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.2 | 0.9 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 0.7 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.2 | 1.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.7 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.4 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.2 | 0.4 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.2 | 0.7 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.2 | 0.4 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.2 | 0.2 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) |
0.2 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.2 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.3 | GO:0003159 | endocardium development(GO:0003157) morphogenesis of an endothelium(GO:0003159) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.2 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 1.6 | GO:1902583 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.2 | 0.3 | GO:0001705 | ectoderm formation(GO:0001705) |
0.2 | 2.8 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.2 | 2.4 | GO:0016236 | macroautophagy(GO:0016236) |
0.2 | 0.9 | GO:2000142 | regulation of transcription initiation from RNA polymerase II promoter(GO:0060260) regulation of DNA-templated transcription, initiation(GO:2000142) |
0.2 | 1.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.3 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.2 | 1.4 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.2 | 1.2 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.2 | 0.3 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.2 | 0.2 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.2 | 0.7 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.2 | 2.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.2 | GO:0046931 | pore complex assembly(GO:0046931) |
0.2 | 0.2 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.2 | 2.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 0.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.3 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 0.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.2 | 0.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 2.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 1.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.2 | 0.5 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 1.0 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.2 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.2 | 0.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 1.1 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.2 | 1.3 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.2 | 0.2 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.2 | 0.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.2 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.2 | 0.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 1.8 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 1.1 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 1.3 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.2 | 1.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 0.5 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 1.3 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.2 | 0.8 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.2 | 0.2 | GO:1902305 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.2 | 1.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 1.3 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.2 | 0.5 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 0.8 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.2 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.2 | 0.8 | GO:1901571 | icosanoid secretion(GO:0032309) icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.2 | 0.5 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.2 | 0.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 0.6 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.2 | 1.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.5 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 1.5 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 0.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.6 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.2 | 0.8 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 2.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.3 | GO:0032048 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.2 | 0.2 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.2 | 0.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.9 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.2 | 0.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.3 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.7 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 3.7 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 1.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.6 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 1.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 12.5 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 2.8 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.1 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 0.9 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 3.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 3.7 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 0.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.4 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 2.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 1.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.4 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.1 | 0.4 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.3 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.1 | 0.6 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 4.2 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 6.8 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.5 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 0.3 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 0.3 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.1 | 1.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.9 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 1.1 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.1 | 0.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 0.3 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.1 | 0.5 | GO:0051340 | regulation of ligase activity(GO:0051340) |
0.1 | 2.7 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 3.2 | GO:0043928 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 1.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 2.3 | GO:0046649 | lymphocyte activation(GO:0046649) |
0.1 | 0.9 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.8 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.3 | GO:0045010 | actin nucleation(GO:0045010) |
0.1 | 0.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 6.0 | GO:0019395 | fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
0.1 | 0.5 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.1 | 1.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 3.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 1.0 | GO:0051322 | anaphase(GO:0051322) |
0.1 | 0.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.1 | 0.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 9.7 | GO:0050657 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
0.1 | 0.1 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 0.8 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.6 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.1 | 0.4 | GO:0021780 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 1.0 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.9 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.4 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 1.0 | GO:0019184 | glutathione biosynthetic process(GO:0006750) nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.9 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.8 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 3.1 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.1 | 0.9 | GO:0035967 | cellular response to topologically incorrect protein(GO:0035967) |
0.1 | 1.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.7 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.1 | 0.1 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.1 | 0.4 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 2.3 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.1 | 0.2 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.4 | GO:1903319 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.1 | 0.5 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.1 | 1.3 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.5 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.7 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 4.1 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.7 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 1.1 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.1 | 36.7 | GO:0006955 | immune response(GO:0006955) |
0.1 | 0.2 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.4 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.7 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.9 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.1 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.1 | 0.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.9 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.1 | 1.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 4.2 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.5 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.5 | GO:0050684 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
0.1 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.3 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.1 | 0.2 | GO:0000239 | pachytene(GO:0000239) |
0.1 | 0.7 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 2.3 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.9 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 4.0 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.1 | 20.0 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 0.1 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.1 | 0.1 | GO:1904358 | regulation of telomere maintenance via telomerase(GO:0032210) positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.1 | 0.4 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.1 | 0.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.2 | GO:0033133 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.2 | GO:0046398 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.1 | 0.5 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.1 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 1.2 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.1 | 1.3 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 0.6 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.1 | 0.2 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.2 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.1 | 0.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.4 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.1 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 1.9 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.1 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0070977 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.1 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.1 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.1 | 0.5 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.3 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.1 | 0.2 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.1 | 0.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.5 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 0.2 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.1 | 0.4 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 7.7 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 6.8 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 5.7 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 1.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 3.3 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.4 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.4 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 5.9 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.6 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 2.5 | GO:0006818 | hydrogen transport(GO:0006818) |
0.1 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.3 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.7 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 2.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 6.1 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 3.3 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 3.7 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.1 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.8 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.3 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:0060456 | regulation of saliva secretion(GO:0046877) positive regulation of digestive system process(GO:0060456) |
0.1 | 0.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.2 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.2 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 | 0.7 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 1.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 3.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.3 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.2 | GO:0044774 | mitotic DNA integrity checkpoint(GO:0044774) |
0.1 | 0.2 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.3 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.2 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.1 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.5 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.2 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 0.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.2 | GO:0090022 | regulation of granulocyte chemotaxis(GO:0071622) regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.1 | 0.5 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.2 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.1 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.4 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 2.2 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.2 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.5 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.2 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.1 | 0.1 | GO:0060117 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) auditory receptor cell development(GO:0060117) |
0.1 | 0.1 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.1 | 0.5 | GO:0007005 | mitochondrion organization(GO:0007005) |
0.1 | 0.2 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.3 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.1 | 8.7 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 4.9 | GO:0006364 | rRNA processing(GO:0006364) rRNA metabolic process(GO:0016072) |
0.1 | 0.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 4.4 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.1 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.4 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 0.9 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.1 | 0.4 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.2 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) metaphase plate congression(GO:0051310) |
0.1 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.4 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.1 | 0.4 | GO:0000819 | sister chromatid segregation(GO:0000819) |
0.1 | 0.9 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.3 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.1 | 0.2 | GO:0006312 | mitotic recombination(GO:0006312) |
0.1 | 0.4 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 1.3 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.1 | 0.9 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.1 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.3 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.1 | 0.2 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.1 | 3.4 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.9 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.3 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.1 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.1 | 0.1 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.4 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.4 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.1 | GO:0065005 | high-density lipoprotein particle assembly(GO:0034380) protein-lipid complex assembly(GO:0065005) |
0.1 | 0.5 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.9 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 0.2 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 0.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.1 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.1 | 0.2 | GO:0072666 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.1 | 0.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.1 | 0.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.1 | 0.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 0.2 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.1 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 10.6 | GO:0006412 | translation(GO:0006412) |
0.1 | 0.6 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.1 | 0.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.2 | GO:0021694 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 1.0 | GO:0072655 | protein localization to mitochondrion(GO:0070585) establishment of protein localization to mitochondrion(GO:0072655) |
0.1 | 0.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 1.1 | GO:0002682 | regulation of immune system process(GO:0002682) |
0.1 | 0.1 | GO:0001743 | optic placode formation(GO:0001743) |
0.1 | 0.8 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.1 | 0.3 | GO:0070972 | protein targeting to ER(GO:0045047) protein localization to endoplasmic reticulum(GO:0070972) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.2 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.6 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.3 | GO:0002440 | production of molecular mediator of immune response(GO:0002440) |
0.1 | 0.3 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.2 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.0 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.0 | 0.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.2 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 0.0 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.0 | GO:0043247 | telomere capping(GO:0016233) protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 4.5 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.1 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.0 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.3 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.0 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.0 | 0.0 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.0 | 0.2 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.0 | 0.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 1.1 | GO:1901607 | alpha-amino acid biosynthetic process(GO:1901607) |
0.0 | 0.2 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.5 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 1.0 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
0.0 | 0.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 1.6 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.1 | GO:0030147 | obsolete natriuresis(GO:0030147) |
0.0 | 0.0 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.4 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.0 | 0.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.7 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.2 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.2 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.0 | 0.6 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.1 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.0 | 0.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.0 | GO:0015793 | renal water transport(GO:0003097) glycerol transport(GO:0015793) cellular response to mercury ion(GO:0071288) |
0.0 | 1.0 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 0.1 | GO:0015851 | nucleobase transport(GO:0015851) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 5.4 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 | 0.0 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.0 | 0.1 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.1 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.3 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.0 | 0.1 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.0 | GO:0060896 | neural plate pattern specification(GO:0060896) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 1.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.0 | GO:0055069 | cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
0.0 | 0.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.0 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.6 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.0 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.0 | 0.1 | GO:0006997 | nucleus organization(GO:0006997) |
0.0 | 0.1 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.0 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.1 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.1 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.6 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.2 | GO:0043414 | macromolecule methylation(GO:0043414) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.2 | GO:0051899 | membrane depolarization(GO:0051899) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.5 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.0 | GO:0033505 | floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.6 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 0.0 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0051904 | pigment granule transport(GO:0051904) |
0.0 | 0.0 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.0 | 0.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.2 | GO:0048925 | sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
0.0 | 0.6 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 1.7 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.0 | GO:0032623 | interleukin-2 production(GO:0032623) |
0.0 | 0.2 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.0 | 0.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.0 | 0.0 | GO:0070227 | lymphocyte apoptotic process(GO:0070227) regulation of lymphocyte apoptotic process(GO:0070228) T cell apoptotic process(GO:0070231) regulation of T cell apoptotic process(GO:0070232) |
0.0 | 0.0 | GO:0030832 | regulation of actin filament length(GO:0030832) |
0.0 | 0.0 | GO:0051304 | chromosome separation(GO:0051304) |
0.0 | 0.1 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 1.7 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 0.0 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.0 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.0 | 4.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 4.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.1 | 2.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.0 | 12.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.9 | 3.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.8 | 1.7 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.8 | 4.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.7 | 2.2 | GO:0072487 | MSL complex(GO:0072487) |
0.7 | 2.1 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.7 | 5.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.5 | 1.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 4.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.5 | 3.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.5 | 2.4 | GO:0070695 | FHF complex(GO:0070695) |
0.5 | 1.4 | GO:0032009 | early phagosome(GO:0032009) |
0.5 | 2.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 5.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 3.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.4 | 0.4 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.4 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 2.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 1.6 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 1.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 1.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.3 | 1.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 1.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 1.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 3.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 4.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 2.3 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.3 | 0.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 0.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 0.9 | GO:0031904 | endosome lumen(GO:0031904) |
0.3 | 1.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 1.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 1.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 0.9 | GO:0001652 | granular component(GO:0001652) |
0.3 | 1.7 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.3 | 2.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 1.1 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.3 | 1.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 5.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 0.8 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.3 | 0.8 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.3 | 2.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 1.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 0.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 1.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 1.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 2.5 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.2 | 1.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 1.0 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 2.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 1.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 3.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.7 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.2 | 0.7 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 0.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.9 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.2 | 0.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 1.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 0.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 14.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 0.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.2 | 2.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 0.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 1.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 2.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 1.2 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.2 | 1.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 2.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.8 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 1.8 | GO:0022624 | proteasome regulatory particle(GO:0005838) proteasome accessory complex(GO:0022624) |
0.2 | 10.3 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.6 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 0.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 3.2 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.2 | 1.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 1.1 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 3.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 0.7 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 1.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 0.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 0.6 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.2 | 0.7 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.2 | 2.1 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 1.6 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 1.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 0.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 0.5 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 2.2 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 1.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.5 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.2 | 1.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 4.7 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.2 | 0.2 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 3.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 5.9 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.2 | 0.3 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.2 | 1.0 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.2 | 1.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 1.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 1.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 1.7 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 2.0 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 14.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 2.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 1.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 4.8 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 5.2 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.2 | 2.5 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 33.6 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 0.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 1.2 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 1.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.9 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.1 | 3.0 | GO:0042612 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
0.1 | 1.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 1.6 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.1 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 1.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.6 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 0.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 3.6 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 5.3 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 1.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 1.9 | GO:0005844 | polysome(GO:0005844) |
0.1 | 1.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 6.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.8 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 1.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 2.8 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.5 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 1.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.3 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.6 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.4 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 1.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.9 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.2 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.1 | 2.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 2.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 1.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.6 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 2.1 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 1.4 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.6 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 7.1 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.2 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.1 | 0.6 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 1.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 9.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.3 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 1.1 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 5.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 1.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 72.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 4.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 2.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 1.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 1.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 1.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 5.7 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.1 | 1.5 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.6 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.4 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.7 | GO:0030684 | preribosome(GO:0030684) |
0.1 | 0.2 | GO:0001741 | XY body(GO:0001741) |
0.1 | 2.0 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 2.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 25.7 | GO:0005768 | endosome(GO:0005768) |
0.1 | 6.6 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 2.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 10.0 | GO:0005819 | spindle(GO:0005819) |
0.1 | 1.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.4 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 0.8 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 0.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.9 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.4 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 109.1 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 1.3 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.3 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 4.8 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 1.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 6.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 3.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 1.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.2 | GO:0005903 | brush border(GO:0005903) |
0.1 | 21.4 | GO:0044429 | mitochondrial part(GO:0044429) |
0.1 | 1.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.5 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 2.3 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.3 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.1 | 3.7 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 31.8 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.7 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.2 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.2 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.1 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 2.8 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.8 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.1 | 0.8 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 1.2 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 19.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 15.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.3 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.0 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 3.8 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.1 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.0 | 0.1 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.0 | 0.2 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.0 | 0.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.6 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.0 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 2.3 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.0 | 0.1 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.0 | 0.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.4 | 4.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.2 | 3.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.9 | 5.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.8 | 5.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.8 | 3.9 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.8 | 2.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.8 | 2.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.8 | 2.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.7 | 2.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.7 | 2.9 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.7 | 2.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.7 | 2.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.7 | 11.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 1.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.6 | 4.7 | GO:0005522 | profilin binding(GO:0005522) |
0.6 | 1.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.6 | 1.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.5 | 3.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.5 | 2.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.5 | 2.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.5 | 4.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 1.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 3.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.5 | 1.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.5 | 1.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.5 | 2.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 5.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.5 | 2.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.5 | 4.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 1.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.4 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 22.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 4.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 2.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 1.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 1.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 1.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 1.7 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 1.7 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.4 | 2.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 4.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.4 | 16.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 1.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.4 | 2.5 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.4 | 1.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 2.4 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.4 | 2.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.4 | 7.1 | GO:0043621 | protein self-association(GO:0043621) |
0.4 | 3.2 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.4 | 2.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 1.2 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.4 | 3.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 3.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.4 | 1.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.4 | 1.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.4 | 1.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 2.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.4 | 1.5 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.4 | 2.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.4 | 1.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 1.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.4 | 1.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 1.8 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.3 | 1.0 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.3 | 1.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.3 | 0.7 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 1.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.3 | 1.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 1.3 | GO:0045569 | TRAIL binding(GO:0045569) |
0.3 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 1.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 1.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 2.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 1.9 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 1.0 | GO:0004875 | complement receptor activity(GO:0004875) |
0.3 | 1.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 0.9 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 0.3 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.3 | 0.3 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.3 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.3 | 0.9 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 4.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.3 | 0.9 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.3 | 1.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 0.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 0.9 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.3 | 2.6 | GO:0019864 | IgG binding(GO:0019864) |
0.3 | 1.2 | GO:0004340 | glucokinase activity(GO:0004340) |
0.3 | 1.2 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 1.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 0.9 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 1.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 2.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 0.8 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.3 | 2.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 0.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 1.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.3 | 1.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 1.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 0.3 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.3 | 0.8 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.3 | 0.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.3 | 0.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 1.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 0.8 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.3 | 1.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 5.5 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 0.8 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 4.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 0.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 3.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 1.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 0.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 3.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.3 | 2.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 0.5 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.3 | 2.8 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 0.8 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.3 | 2.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.3 | 3.3 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.2 | 1.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 1.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 1.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 0.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 7.4 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 1.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 1.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 1.2 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.2 | 6.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 0.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 1.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 0.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 1.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 2.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 3.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.9 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 0.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 0.4 | GO:0003917 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
0.2 | 1.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 0.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 2.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 1.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.7 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.2 | 1.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.2 | 2.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 1.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 1.5 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.2 | 0.9 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.2 | 0.7 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 2.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 0.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 1.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 0.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 2.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.9 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.6 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.2 | 0.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.2 | 0.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 4.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.2 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.2 | 0.4 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 1.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 2.5 | GO:0017069 | snRNA binding(GO:0017069) |
0.2 | 1.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 1.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.8 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 0.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 1.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 1.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 5.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.2 | 1.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.2 | 0.6 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.2 | 0.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 0.2 | GO:0004396 | hexokinase activity(GO:0004396) |
0.2 | 2.9 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 1.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.2 | 0.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.2 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 5.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.8 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 1.3 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.2 | 0.6 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 1.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 3.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.6 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 0.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 0.6 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.2 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 6.0 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.2 | 0.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 0.9 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 1.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 7.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 0.5 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.2 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 0.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.5 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 1.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 0.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 0.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 1.1 | GO:0061659 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 0.5 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.2 | 0.5 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.2 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 3.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 0.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 0.2 | GO:0005035 | death receptor activity(GO:0005035) |
0.2 | 1.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 4.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 4.2 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 0.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.2 | 1.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.2 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.2 | 7.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 0.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 1.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 6.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 1.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.5 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 2.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 1.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 2.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 1.6 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 0.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 0.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 2.1 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.2 | 0.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.5 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.2 | 2.4 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.2 | 1.6 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.2 | 4.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 0.6 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 0.8 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.2 | 0.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 0.6 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 5.5 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 6.4 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 0.3 | GO:0034617 | nitric-oxide synthase activity(GO:0004517) tetrahydrobiopterin binding(GO:0034617) |
0.2 | 0.9 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 0.8 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.2 | 0.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 1.6 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.7 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 1.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.6 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 1.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 7.0 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.4 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 1.6 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 5.3 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 1.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 3.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.6 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 2.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 1.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.3 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.1 | 0.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.5 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 4.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.1 | 1.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.7 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.4 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.3 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.4 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 1.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.4 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 2.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.6 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 1.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.5 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 2.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.4 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.1 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 1.1 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 1.9 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 1.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 4.4 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 0.7 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 0.1 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.1 | 2.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.7 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 1.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.1 | 1.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.3 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 1.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 1.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.1 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.1 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 1.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 1.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.4 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 2.3 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 11.7 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 1.8 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 1.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 3.3 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 6.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.5 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.4 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.5 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 4.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.4 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 3.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 2.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 1.0 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 1.3 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 1.8 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 2.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 1.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.7 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.5 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 7.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.3 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.1 | 0.2 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 1.4 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.2 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 0.6 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.1 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.1 | 0.6 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.1 | 0.1 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.6 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.1 | 0.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 17.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 8.2 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.1 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.9 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 1.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.3 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.7 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.9 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.1 | 0.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 1.6 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 1.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.4 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 3.5 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.1 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 1.1 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.1 | 3.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.4 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.6 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.1 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 19.3 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 10.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 1.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.7 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.4 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.3 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 11.6 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 1.3 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 1.1 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 1.3 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.9 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 20.9 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.9 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.5 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.0 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0043121 | neurotrophin receptor activity(GO:0005030) neurotrophin binding(GO:0043121) |
0.0 | 0.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.0 | 0.1 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.3 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.1 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 1.5 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.2 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.5 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.0 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.9 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.1 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.9 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.2 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 3.2 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.2 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 2.3 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.0 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 2.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.6 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.3 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 2.8 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 2.4 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.6 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.0 | 0.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 5.7 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.7 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.0 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 2.0 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.7 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.0 | 0.1 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.3 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 1.0 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 1.0 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.0 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.1 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.0 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.0 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.1 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.0 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.0 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 4.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.0 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 13.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.8 | 46.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.7 | 5.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.7 | 17.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.7 | 2.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.7 | 5.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.7 | 8.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.7 | 4.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.6 | 9.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 4.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.6 | 17.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.6 | 15.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 2.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.4 | 3.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 3.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 7.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.4 | 7.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 5.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 7.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 9.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.4 | 3.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 4.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 11.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 3.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 1.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 1.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.3 | 2.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 2.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 1.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 3.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 3.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 5.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 8.1 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 1.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 1.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 9.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 3.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 2.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 0.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 3.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 3.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 0.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 2.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 2.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 1.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 3.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 0.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 1.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 4.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 2.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.5 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 3.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 4.2 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 5.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 3.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 4.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 3.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 2.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 3.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 3.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 3.9 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 1.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.6 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 3.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 3.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 2.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 2.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 3.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.2 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 1.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.0 | ST ADRENERGIC | Adrenergic Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 15.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.0 | 12.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.9 | 9.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.9 | 13.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.9 | 2.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.7 | 0.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.6 | 10.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.6 | 7.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.6 | 14.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.6 | 1.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.5 | 4.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.5 | 4.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 1.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.5 | 22.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 6.7 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.4 | 4.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 6.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 4.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.4 | 4.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.4 | 1.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 7.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.4 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 7.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.4 | 2.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 6.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.4 | 3.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 6.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 11.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 3.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 2.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 1.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 8.8 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.3 | 2.6 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.3 | 5.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 0.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.3 | 0.6 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.3 | 0.8 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.3 | 1.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 0.3 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.3 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.3 | 5.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 4.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 3.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 1.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.3 | 2.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 16.2 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.2 | 2.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 4.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 6.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 7.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 1.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 3.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 1.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 0.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 0.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 2.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 2.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 1.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 2.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 7.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 4.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 3.0 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.2 | 2.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 7.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 3.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 6.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 4.8 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 1.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.2 | 0.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 1.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 6.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 0.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 1.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 0.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 3.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 1.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 1.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 2.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 0.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 0.5 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.2 | 4.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 0.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 2.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 11.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.2 | 2.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 1.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 8.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 6.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 1.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 13.5 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 2.8 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.7 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.1 | 1.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 2.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 11.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.0 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 1.9 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 2.3 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 2.5 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 1.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 2.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 2.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 1.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 6.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 2.8 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 1.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 0.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 0.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 1.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 2.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 2.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 1.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 2.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 3.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 5.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.8 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.1 | 1.8 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.1 | 0.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 2.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 5.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.3 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.9 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 4.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 1.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 0.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 3.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.5 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.3 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.1 | 2.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 2.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.2 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.1 | 1.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 7.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.4 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.1 | 1.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.2 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 9.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.7 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 2.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 2.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 1.5 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.0 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.1 | 0.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.5 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.1 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 1.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 3.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.7 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 0.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.3 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.6 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.0 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 2.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.2 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.0 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.0 | 0.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 3.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |